AzTrials
AzTrials

Postoperative DeliriumNCT05368272

EEG Spectrogram, Brain Vulnerability and POD

An observational study of Postoperative Delirium, run by University of Nottingham at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

An assessment of difference in prespecified processed electroencephalography variables between cognitively intact older surgical patients who develop postoperative delirium compared to those who do not develop postoperative delirium Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Postoperative Delirium
What is being tested?
Processed electroencephalography and Postoperative delirium assessment
How many people
30 participants
Where
1 siteUnited Kingdom
Study dates
27 Jan 2023to 6 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Older people scheduled for elective major surgery at a large teaching hospital

Who may be able to join

  • ≥ 65 years old
  • Elective, moderate/major, non-neuro, non-cardiac surgery
  • Ability to give informed consent

Who cannot join

  • Preoperative cognitive impairment
  • Current systemic infection
  • Current use of medication that may modify EEG
  • History of neurosurgery/significant head trauma
  • Presence of neurological diseases including overt stroke, dementia, epilepsy, multiple sclerosis, Parkinson's disease, intracranial tumours and other significant neurologic disorders
  • Current significant psychiatric conditions such as severe depression.
  • Palliative surgery

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Queen's Medical Centre

    Nottingham

Other trials in United Kingdom

About this study

Official title: EEG Spectrogram to Assess Brain Vulnerability as a Risk Factor for Postoperative Delirium in Older People - a Feasibility Study

An assessment of difference in prespecified processed electroencephalography variables between cognitively intact older surgical patients who develop postoperative delirium compared to those who do not develop postoperative delirium

Read the detailed description

Postoperative delirium in older people may be contributed to by intrinsic brain vulnerability such as pre-existing dementia. Some cognitively intact older people also experience postoperative delirium and in these patients some go on to develop later dementia. The investigators propose that postoperative delirium may be an unmasking of covert brain vulnerability by the dyshomeostasis of the anaesthesia/surgical intervention.

In people with dementia or mild cognitive impairment, electroencephalography (EEG) studies have shown slowing of brain wave activity, especially in the back of the brain.

Processed electroencephalography, using a limited number of channels, is routinely used during anaesthesia to aid assessment of anaesthetic depth of the patient.

In this study the investigators will assess the feasibility of acquiring EEG data from the front and back of the brain. The investigators will also explore the data for early signals of brain vulnerability

Being tested
Processed electroencephalography, Postoperative delirium assessment
Keywords
processed EEG, Postoperative vulnerability, Older people, Brain vulnerability
Medical subject headings
Emergence Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Processed electroencephalographyOther

    Acquisition of raw EEG data from processed EEG monitor. Analysis of data acquired for prespecified bandwidth properties

  • Postoperative delirium assessmentOther

    Twice daily assessment for the incidence of postoperative delirium using validated tool (questionnaire)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of acquiring frontal and posterior EEG data from the Narcotrend monitor during the preoperative and intraoperative period

    Feasibility will be assessed by the ability to get preoperative and intraoperative epochs of EEG that clearly demonstrates the different brain wave bands (alpha, theta and delta)

    Measured: Approximately 1 - 2 hours per participant

Secondary outcomes (3)
  1. Preoperative brain wave differences

    Identify any differences in frontal and posterior narrowband (i.e. alpha, delta and theta) power preoperatively between older people who develop POD compared to those who do not.

    Measured: Approximately 10 minutes per participant

  2. Change in brain wave power due to induction of anaesthesia

    Identify if the change in narrowband power from the preoperative values to steady state intraoperative values are different between groups (i.e. people who develop POD vs people who do not develop POD)

    Measured: Approximately 1 hour per particpant

  3. Intraoperative brain wave patterns

    Identify any differences in mean and spectral edge frequencies preoperatively and intraoperatively between older people who develop POD and those who do not.

    Measured: Duration of surgery or 2 hours (shortest option)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 May 2022
  2. Study start27 Jan 2023
  3. Primary completion6 Dec 2023
  4. Study completion6 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05368272
Sponsor's protocol ID
21074
Status last verified
Feb 2024
First submitted
5 May 2022
Last updated
28 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Delirium, run by University of Nottingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of acquiring frontal and posterior EEG data from the Narcotrend monitor during the preoperative and intraoperative period (time frame: Approximately 1 - 2 hours per participant). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in